Nominations to the Report on Carcinogens and Office of Health Assessment and Translation; Request for Information, 60692-60693 [2015-25434]

Download as PDF 60692 Federal Register / Vol. 80, No. 194 / Wednesday, October 7, 2015 / Notices Dated: October 2, 2015. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–25481 Filed 10–6–15; 8:45 am] BILLING CODE 4140–01–P Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: October 1, 2015. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–25441 Filed 10–6–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Dated: October 1, 2015. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings National Institutes of Health asabaliauskas on DSK5VPTVN1PROD with NOTICES VerDate Sep<11>2014 18:12 Oct 06, 2015 Jkt 238001 National Institute of Diabetes and Digestive and Kidney Diseases; Amended Notice of Meeting National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Systems Biology and Antibacterial Resistance (U01). Date: November 2–3, 2015. Time: 8:00 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, Montrose Meeting Room, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Eleazar Cohen, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room 3G62A, National Institute of Health, NIAID, 5601 Fishers Lane, MSC 9823, Bethesda, MD 20899823, (240) 669–5081, ecohen@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, NIAID Peer Review Meeting. Date: November 12, 2015. Time: 8:30 a.m. to 5:30 p.m. Agenda: To review and evaluate contract proposals. Place: Doubletree Hotel Bethesda, Harmony Room, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Lynn Rust, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, room 3G42A, National Institutes of Health/ NIAID, 5601 Fishers Lane, MSC 9823, Bethesda, MD 20892–9823, (240) 669–5069, lrust@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, National Institutes of Health Notice is hereby given of a change in the meeting of the National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, September 25, 2015, 09:00 a.m. to September 25, 2015, 12:00 p.m., National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD, 20892 which was published in the Federal Register on September 08, 2015, Vol. 80, No. 173. This meeting is being amended to reflect a date and time change. The meeting will be held on December 15, 2015, from 04:00 p.m. until 06:00 p.m. The meeting is closed to the public. National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. DEPARTMENT OF HEALTH AND HUMAN SERVICES Name of Committee: National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel, NIAAA AA–1 Member Conflict Applications [ZAA1 GG (01)]. Date: November 23, 2015. Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: NIAAA, NIH, 5635 Fishers Lane, CR2098, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Richard Rippe, Ph.D., Scientific Review Officer, National Institute on Alcohol Abuse and Alcoholism, NIH, 5635 Fishers Lane; Room 2019, Rockville, MD 20852, (301) 443–8599, rippera@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Career Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 92.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants; 93.701, ARRA Related Biomedical Research and Research Supports Awards, National Institutes of Health, HHS) Dated: October 2, 2015. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–25482 Filed 10–6–15; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 [FR Doc. 2015–25440 Filed 10–6–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Nominations to the Report on Carcinogens and Office of Health Assessment and Translation; Request for Information National Toxicology Program (NTP) Office of the Report on Carcinogens (ORoC) and Office of Health Assessment and Translation (OHAT) request information on nine substances, mixtures, and exposure circumstances (collectively referred to as ‘‘substances’’). Six substances are nominated for possible review for future editions of the Report on Carcinogens (RoC). Three substances are being considered by OHAT for evaluation of non-cancer health outcomes. DATES: Deadline for receipt of information is November 6, 2015. ADDRESSES: Information on substances for possible review for the RoC should be submitted electronically on the ORoC nominated substances page (https:// ntp.niehs.nih.gov/go/rocnom) or to lunn@niehs.nih.gov. Information on OHAT nominations can be submitted electronically on the OHAT nominated topics page (https://ntp.niehs.nih.gov/go/ 763346) or to thayer@niehs.nih.gov. SUMMARY: E:\FR\FM\07OCN1.SGM 07OCN1 Federal Register / Vol. 80, No. 194 / Wednesday, October 7, 2015 / Notices RoC Nominations: Dr. Ruth Lunn, Director, ORoC; telephone (919) 316–4637; lunn@ niehs.nih.gov. OHAT Nominations: Dr. Kristina Thayer, Director, OHAT, telephone (919) 541–5021; thayer@ niehs.nih.gov. Address for Dr. Lunn and Dr. Thayer: DNTP, NIEHS, 111 T.W. Alexander Drive, P.O. Box 12233, Research Triangle Park, NC 27709. SUPPLEMENTARY INFORMATION: Request for Information: The NTP requests information on nine substances: Six substances have been nominated for possible review for future editions of the RoC (see https://ntp.niehs.nih.gov/go/ rocnom) and three are under consideration by OHAT for evaluation of non-cancer health outcomes. (see https://ntp.niehs.nih.gov/go/763346). Specifically, NTP requests information on each substance regarding: (1) Data on current production, use patterns, and human exposure; (2) published, ongoing, or planned studies related to evaluating adverse health outcomes (e.g., cancer, development, reproductive, or immunological disorders); (3) scientific issues important for prioritizing and assessing adverse health outcomes; and (4) names of scientists with expertise or knowledge about the substance—please include any bibliographic citations when available. NTP will use this information in determining which substances to propose for formal health hazard evaluations. FOR FURTHER INFORMATION CONTACT: Six Substances Nominated for Possible Review for the RoC * Flame Retardants • Pentabromodiphenyl ether mixture (DE–71) • Tetrabromobisphenol A, CASRN 79– 94–7 Water Disinfection Byproducts • Dibromoacetonitrile, CASRN 3252– 43–5 • Di- and tri-haloacetic acids (as a class); specifically, those haloacetic acids with similar functional or structural properties that may cause similar health hazards asabaliauskas on DSK5VPTVN1PROD with NOTICES Other • Fluoride, CASRN 7681–49–4 • Vinylidene chloride, CASRN 5–35–4 * Evaluations for the RoC may seek to list a new substance in the report, reclassify the listing status of a substance already listed, or remove a listed substance. Three substances are being considered for OHAT evaluation of non-cancer health outcomes. VerDate Sep<11>2014 18:12 Oct 06, 2015 Jkt 238001 • Mountaintop removal mining (health impacts on surrounding communities) • Neonicotinoid pesticides • Fluoride (developmental neurotoxicity and endocrine disruption) Information on RoC nominations should be submitted electronically on the ORoC nomination page (https://ntp.niehs.nih.gov/go/rocnom) or by email to lunn@niehs.nih.gov. Information on OHAT nominations should be submitted electronically on the OHAT nominated topics page (https://ntp.niehs.nih.gov/go/763346) or to thayer@niehs.nih.gov. Public comments should include the submitter’s name, affiliation, sponsoring organization (if any) along with appropriate contact information (telephone and email). Written information received in response to this notice will be posted on the NTP Web site, and the submitter identified by name, affiliation, and/or sponsoring organization. Responses to this request for information are voluntary. This request for information is for planning purposes only and is not a solicitation for applications or an obligation on the part of the U.S. Government to provide support for any ideas identified in response to it. Please note that the U.S. Government will not pay for the preparation of any information submitted or for its use. No proprietary, classified, confidential, or sensitive information should be included in your response. Background Information on ORoC: On behalf of NTP, ORoC manages preparation of the RoC following an established, four-part process (https:// ntp.niehs.nih.gov/go/rocprocess). The RoC is a congressionally mandated, science-based, public health report that identifies agents, substances, mixtures, or exposures (collectively called ‘‘substances’’) in our environment that pose a cancer hazard for people in the United States. Published biennially, each edition of the RoC is cumulative and consists of substances newly reviewed in addition to those listed in previous editions. Newly reviewed substances with their recommended listing are reviewed and approved by the Secretary of Health and Human Services. The 13th RoC, the latest edition, was published on October 2, 2014 (available at https:// ntp.niehs.nih.gov/go/roc13). The 14th RoC is under development. Background Information on OHAT: On behalf of NTP, OHAT conducts literature-based evaluations to assess the evidence that environmental chemicals, PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 60693 physical substances, or mixtures (collectively referred to as ‘‘substances’’) cause adverse non-cancer health outcomes. As part of these evaluations, NTP may also provide opinions on whether these substances might be of concern for causing adverse effects on human health given what is known about toxicity and current human exposure levels. Dated: October 1, 2015. John R. Bucher, Associate Director, National Toxicology Program. [FR Doc. 2015–25434 Filed 10–6–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, Look AHEAD Brain MRI–2. Date: December 1, 2015. Time: 1:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Paul A. Rushing, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 747, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–8895, rushingp@extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) E:\FR\FM\07OCN1.SGM 07OCN1

Agencies

[Federal Register Volume 80, Number 194 (Wednesday, October 7, 2015)]
[Notices]
[Pages 60692-60693]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-25434]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Nominations to the Report on Carcinogens and Office of Health 
Assessment and Translation; Request for Information

SUMMARY: National Toxicology Program (NTP) Office of the Report on 
Carcinogens (ORoC) and Office of Health Assessment and Translation 
(OHAT) request information on nine substances, mixtures, and exposure 
circumstances (collectively referred to as ``substances''). Six 
substances are nominated for possible review for future editions of the 
Report on Carcinogens (RoC). Three substances are being considered by 
OHAT for evaluation of non-cancer health outcomes.

DATES: Deadline for receipt of information is November 6, 2015.

ADDRESSES: Information on substances for possible review for the RoC 
should be submitted electronically on the ORoC nominated substances 
page (https://ntp.niehs.nih.gov/go/rocnom) or to lunn@niehs.nih.gov. 
Information on OHAT nominations can be submitted electronically on the 
OHAT nominated topics page (https://ntp.niehs.nih.gov/go/763346) or to 
thayer@niehs.nih.gov.

[[Page 60693]]


FOR FURTHER INFORMATION CONTACT: RoC Nominations: Dr. Ruth Lunn, 
Director, ORoC; telephone (919) 316-4637; lunn@niehs.nih.gov. OHAT 
Nominations: Dr. Kristina Thayer, Director, OHAT, telephone (919) 541-
5021; thayer@niehs.nih.gov. Address for Dr. Lunn and Dr. Thayer: DNTP, 
NIEHS, 111 T.W. Alexander Drive, P.O. Box 12233, Research Triangle 
Park, NC 27709.

SUPPLEMENTARY INFORMATION: Request for Information: The NTP requests 
information on nine substances: Six substances have been nominated for 
possible review for future editions of the RoC (see https://ntp.niehs.nih.gov/go/rocnom) and three are under consideration by OHAT 
for evaluation of non-cancer health outcomes. (see https://ntp.niehs.nih.gov/go/763346). Specifically, NTP requests information on 
each substance regarding: (1) Data on current production, use patterns, 
and human exposure; (2) published, ongoing, or planned studies related 
to evaluating adverse health outcomes (e.g., cancer, development, 
reproductive, or immunological disorders); (3) scientific issues 
important for prioritizing and assessing adverse health outcomes; and 
(4) names of scientists with expertise or knowledge about the 
substance--please include any bibliographic citations when available. 
NTP will use this information in determining which substances to 
propose for formal health hazard evaluations.

Six Substances Nominated for Possible Review for the RoC *

Flame Retardants

 Pentabromodiphenyl ether mixture (DE-71)
 Tetrabromobisphenol A, CASRN 79-94-7

Water Disinfection Byproducts

 Dibromoacetonitrile, CASRN 3252-43-5
 Di- and tri-haloacetic acids (as a class); specifically, those 
haloacetic acids with similar functional or structural properties that 
may cause similar health hazards

Other

 Fluoride, CASRN 7681-49-4
 Vinylidene chloride, CASRN 5-35-4

    * Evaluations for the RoC may seek to list a new substance in the 
report, reclassify the listing status of a substance already listed, or 
remove a listed substance.

    Three substances are being considered for OHAT evaluation of non-
cancer health outcomes.

 Mountaintop removal mining (health impacts on surrounding 
communities)
 Neonicotinoid pesticides
 Fluoride (developmental neurotoxicity and endocrine 
disruption)

    Information on RoC nominations should be submitted electronically 
on the ORoC nomination page (https://ntp.niehs.nih.gov/go/rocnom) or by 
email to lunn@niehs.nih.gov. Information on OHAT nominations should be 
submitted electronically on the OHAT nominated topics page (https://ntp.niehs.nih.gov/go/763346) or to thayer@niehs.nih.gov. Public 
comments should include the submitter's name, affiliation, sponsoring 
organization (if any) along with appropriate contact information 
(telephone and email). Written information received in response to this 
notice will be posted on the NTP Web site, and the submitter identified 
by name, affiliation, and/or sponsoring organization.
    Responses to this request for information are voluntary. This 
request for information is for planning purposes only and is not a 
solicitation for applications or an obligation on the part of the U.S. 
Government to provide support for any ideas identified in response to 
it. Please note that the U.S. Government will not pay for the 
preparation of any information submitted or for its use. No 
proprietary, classified, confidential, or sensitive information should 
be included in your response.
    Background Information on ORoC: On behalf of NTP, ORoC manages 
preparation of the RoC following an established, four-part process 
(https://ntp.niehs.nih.gov/go/rocprocess). The RoC is a congressionally 
mandated, science-based, public health report that identifies agents, 
substances, mixtures, or exposures (collectively called ``substances'') 
in our environment that pose a cancer hazard for people in the United 
States. Published biennially, each edition of the RoC is cumulative and 
consists of substances newly reviewed in addition to those listed in 
previous editions. Newly reviewed substances with their recommended 
listing are reviewed and approved by the Secretary of Health and Human 
Services. The 13th RoC, the latest edition, was published on October 2, 
2014 (available at https://ntp.niehs.nih.gov/go/roc13). The 14th RoC is 
under development.
    Background Information on OHAT: On behalf of NTP, OHAT conducts 
literature-based evaluations to assess the evidence that environmental 
chemicals, physical substances, or mixtures (collectively referred to 
as ``substances'') cause adverse non-cancer health outcomes. As part of 
these evaluations, NTP may also provide opinions on whether these 
substances might be of concern for causing adverse effects on human 
health given what is known about toxicity and current human exposure 
levels.

    Dated: October 1, 2015.
John R. Bucher,
Associate Director, National Toxicology Program.
[FR Doc. 2015-25434 Filed 10-6-15; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.